Floatz logo

Therapeutic Asset Ratings

3,272 results matching 1 filter

91,564 assets · 7,904 sponsors · 3,128 indications
Methodology v0.2
AssetSponsorPhaseRating
Durvalumab
Ovarian Endometrioid Adenocarcinoma
National Cancer Institute (NCI)P2CCC (53)
Durvalumab
Ovarian Mucinous Adenocarcinoma
National Cancer Institute (NCI)P2CCC (53)
Durvalumab
Ovarian Transitional Cell Carcinoma
National Cancer Institute (NCI)P2CCC (53)
Durvalumab
Undifferentiated Ovarian Carcinoma
National Cancer Institute (NCI)P2CCC (53)
Durvalumab
Primary Peritoneal Serous Adenocarcinoma
National Cancer Institute (NCI)P2CCC (53)
Durvalumab
Uterine Corpus Cancer
National Cancer Institute (NCI)P2CCC (53)
Emavusertib
Acute Myeloid Leukemia With Multilineage Dysplasia
National Cancer Institute (NCI)P2CCC (53)
Emavusertib
Therapy Related Acute Myeloid Leukemia And Myelodysplastic Syndrome
National Cancer Institute (NCI)P2CCC (53)
Ensartinib
Non-Hodgkin Lymphoma
National Cancer Institute (NCI)P2CCC (53)
Ensartinib
Histiocytic Sarcoma
National Cancer Institute (NCI)P2CCC (53)
Ensartinib
Juvenile Xanthogranuloma
National Cancer Institute (NCI)P2CCC (53)
Ensartinib
Langerhans Cell Histiocytosis
National Cancer Institute (NCI)P2CCC (53)
Ensartinib
Malignant Glioma
National Cancer Institute (NCI)P2CCC (53)
Ensartinib
Rhabdomyosarcoma
National Cancer Institute (NCI)P2CCC (53)
Ensartinib
Ependymoma
National Cancer Institute (NCI)P2CCC (53)
Ensartinib
Ewing Sarcoma
National Cancer Institute (NCI)P2CCC (53)
Ensartinib
Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor
National Cancer Institute (NCI)P2CCC (53)
Ensartinib
Glioma
National Cancer Institute (NCI)P2CCC (53)
Ensartinib
Hepatoblastoma
National Cancer Institute (NCI)P2CCC (53)
Ensartinib
Malignant Germ Cell Tumor
National Cancer Institute (NCI)P2CCC (53)
Ensartinib
Medulloblastoma
National Cancer Institute (NCI)P2CCC (53)
Ensartinib
Neuroblastoma
National Cancer Institute (NCI)P2CCC (53)
Ensartinib
Osteosarcoma
National Cancer Institute (NCI)P2CCC (53)
Ensartinib
Peripheral Primitive Neuroectodermal Tumor
National Cancer Institute (NCI)P2CCC (53)
Ensartinib
Central Nervous System Neoplasm
National Cancer Institute (NCI)P2CCC (53)
Showing 1301 to 1325 of 3,272 assets
PreviousPage 53 of 131Next